Li et al. found that quercetin improved insulin resistance and reduced hepatic lipid accumulation by inhibiting the expression of the adipogenic genes SREBP1c and FAS in free fatty acid (FFA) and insulin-induced NAFLD HepG2 cell models, suggesting its potential as a treatment for NAFLD [44]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.